Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

High-throughput screening of active compounds against human respiratory syncytial virus

3 Jul 2019

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Neonatal Respiratory Health Research
Share to Respiratory viral infections research
Share to Tracheal and airway disorders

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 31306912
DOI: 10.1016/j.virol.2019.07.002

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

High-throughput screening of active compounds against human respiratory syncytial virusPMID 31306912Read ↗

New-generation screening assays for the detection of anti-influenza compounds targeting viral and host functionsSemantic proximity Read ↗

Drug candidates and model systems in respiratory syncytial virus antiviral drug discovery.Semantic proximity Read ↗

Identification of Novel Small-Molecule Inhibitors of Severe Acute Respiratory Syndrome-Associated Coronavirus by Chemical GeneticsSemantic proximity Read ↗

Structure-guided design of small-molecule therapeutics against RSV diseaseSemantic proximity Read ↗

Drug repurposing screen identifies lonafarnib as respiratory syncytial virus fusion protein inhibitorSemantic proximity Read ↗

Evaluation of anti-Zika virus activities of broad-spectrum antivirals and NIH clinical collection compounds using a cell-based, high-throughput screen assaySemantic proximity Read ↗

Characterization of novel respiratory syncytial virus inhibitors identified by high throughput screen.Semantic proximity Read ↗

Discovering small-molecule therapeutics against SARS-CoV-2Semantic proximity Read ↗

New pharmacological strategies to fight enveloped virusesSemantic proximity Read ↗

Identification of Novel and Efficacious Chemical Compounds that Disturb Influenza A Virus Entry in vitroSemantic proximity Read ↗

EDP-938, a novel nucleoprotein inhibitor of respiratory syncytial virus, demonstrates potent antiviral activities in vitro and in a non-human primate modelSemantic proximity Read ↗

Antivirals with common targets against highly pathogenic virusesSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.